An international team led by a neurologist at the University of British Columbia and Vancouver Coastal Health has shown that a combination of aspirin and clopidogrel, both common blood thinners, does not prevent recurrence of a common type of stroke, and may even pose serious risks.
Posts Tagged ‘VCHRI’
Sports doc helps reduce Olympic injuries
UBC medical researcher Babak Shadgan, Iran’s first accredited sports physician, is supporting the health and safety of athletes at the 2012 Summer Olympics.
Widely prescribed MS treatment may not slow progression of disease: Vancouver Coastal Health and UBC Research
Researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of British Columbia have published important data in the Journal of the American Medical Association (JAMA) about the impact of a common drug therapy on the progression of multiple sclerosis for people with the relapse-remitting form of the disease.
Federal and provincial ministers break ground for UBC-VCH brain health centre
Representatives of the federal and provincial governments today marked the start of construction of a new centre at the University of British Columbia that will unite brain research and patient care. The Djavad Mowafaghian Centre for Brain Health, expected to open in 2013 at UBC Hospital, will bring together experts in the fields of psychiatry, [...]
UBC-Vancouver Coastal Health researcher discovers new type of spinal cord stem cell
A group led by a University of British Columbia and Vancouver Coastal Health scientist has discovered a type of spinal cord cell that could function as a stem cell, with the ability to regenerate portions of the central nervous system in people with spinal cord injuries, multiple sclerosis or amyotrophic lateral sclerosis (Lou Gehrig’s disease).
Newly identified gene mutation linked to Parkinson’s: UBC research
A team of researchers at the University of British Columbia has identified a genetic mutation that causes late-onset Parkinson’s disease, paving the way to a new target for potential treatments that may halt or cure the debilitating neurodegenerative disease.
Non-invasive wireless near-infrared device provides reliable diagnosis of bladder dysfunction: UBC-VCH-CFRI study
A cell phone-sized, wireless near-infrared device is as reliable as the current “gold standard” invasive tests in determining bladder disease, according to a study by researchers at the University of British Columbia, Vancouver Coastal Health and the Child & Family Research Institute (CFRI).
Adverse drug events costly to health care system: Vancouver Coastal Health-UBC research
Patients who suffer an adverse medical event arising from the use or misuse of medications are more costly to the health care system than other emergency department (ED) patients, say physicians and research scientists at Vancouver General Hospital and the University of British Columbia. Their research, the first to examine the health outcomes and cost of patient care for patients presenting to the ED with adverse drug events, is published today in the Annals of Emergency Medicine.
Strength training for seniors provides sustained cognitive function and economic benefits: Vancouver Coastal Health / UBC research
A one-year follow-up study on seniors who participated in a strength training exercise program shows sustained cognitive benefits as well as savings for the healthcare system. The research, conducted at the Centre for Hip Health and Mobility at Vancouver Coastal Health and the University of British Columbia, is published today in the Archives of Internal Medicine.
Anti-cholesterol drugs could help stave off seizures: UBC-Vancouver Coastal Health research
Statins, the family of drugs used to lower cholesterol, might also reduce the risk of epileptic seizures in people with cardiovascular disease, according to a new statistical study by a drug safety expert at the University of British Columbia and Vancouver Coastal Health Research Institute. The findings could provide the basis for randomized, controlled clinical trials to test the efficacy of the drugs as anti-epileptic medication.
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- June 2009
- April 2009
- February 2009
- December 2008
- October 2008
- August 2008
- July 2008
- May 2008
- March 2008
- December 2005
Categories
- Backgrounder (1)
- Beats (133)
- Arts and Humanities (30)
- Business, Law and Society (36)
- Science, Health and Technology (69)
- University News (54)
- Daily Highlights (1)
- Daily Media Summary (10)
- Across Canada (1)
- International/National (5)
- Local News (3)
- Op/Ed (1)
- Events (6)
- Expert Profile (16)
- Extra (48)
- Hot Topics (28)
- Media Advisory (190)
- Media Release (594)
- News Feed (479)
- News Tip (31)
- Op-ed (6)
- People Profile (18)
- Quotable (58)
- UBC In the News (87)
- UBC People (1688)
- UBC Reports (44)
- UBC Reports Stories (501)
- UBC This Week (186)
- Uncategorized (116)
